Paion competitors

Paion Competitors include Durect, Amarin, Array BioPharma and Amicus Therapeutics.
Add company...
Paion
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
Durect
Durect
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
Amarin
Amarin
Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease.
Array BioPharma
Array BioPharma
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Founding Date
Founding Date
2000
Founding Date
N/A
Founding Date
1991
Founding Date
1998
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Aachen, DE HQ
Locations
Cupertino, US HQ
Locations
Dublin, IE HQ
Bedminster Township, US
Locations
Boulder, US HQ
Miami, US
Boston, US
Phoenix, US
New York, US
Chicago, US
Houston, US
see more
Locations
Cranbury Township, US HQ
Northbridge, AU
Pointe Claire, CA
Puteaux, FR
München, DE
Milano, IT
Tokyo, JP
see more
Employees
Employees
3218% decrease
Employees
885% decrease
Employees
530120% increase
Employees
209
Employees
40023% increase
Valuation ($)
Valuation ($)
185.3 m
Valuation ($)
113.4 m
Valuation ($)
5.8 b
Valuation ($)
5 b
Valuation ($)
3 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$18.6m (FY, 2018)
Revenue (est.)
$229.2m (FY, 2018)
Revenue (est.)
$173.8m (FY, 2018)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$54.5m (FY, 2018)
Cost of goods
N/A
Cost of goods
$14.4m (FY, 2018)
Net income
Net income
N/A
Net income
($25.3m) (FY, 2018)
Net income
($116.4m) (FY, 2018)
Net income
($147.3m) (FY, 2018)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 15.2m
Total funding raised
$ 20m
Total funding raised
$ 70m
Total funding raised
N/A
Total funding raised
$ 88m
For sources of this data, please see the company profileDownload Excel

View company profiles

Durect
HQ
Cupertino, US
Employees
88↓ 5% decrease

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.

View company
Amarin
HQ
Dublin, IE
Employees
530

Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease.

View company
Array BioPharma
HQ
Boulder, US
Employees
209

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

View company
Amicus Therapeutics
HQ
Cranbury Township, US
Employees
400↑ 23% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company